Mark Ewalt
Associate Medical Director, Laboratory Operations, Diagnostic Molecular Pathology, Molecular Diagnostics Service Memorial Sloan Kettering Cancer Center
Seminars
Wednesday 7th October 2026
Accelerating Biomarker-Driven Therapy & Clinical-Trial Enrollment with Rapid Front-Line NGS
12:10 pm
- Learn how rapid front-line targeted NGS enables earlier detection of actionable biomarkers, supporting timely precision oncology treatment decisions and companion diagnostic strategies
- Discover best practices for developing, validating, and implementing a rapid targeted NGS assay that complements comprehensive genomic profiling while accelerating biomarker identification
- Explore how rapid genomic insights can expedite biomarker-driven clinical trial enrollment, improve access to targeted therapies, and support pharmaceutical and diagnostic partners developing companion diagnostics
- See how optimized workflows using the Illumina MiSeq™ i100 Series and Hamilton STARlet can reduce NGS turnaround times, helping bring biomarker-guided therapies and CDx solutions to patients faster
